The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation
Abstract
The influence of busulfan (BU) plasma concentration on outcome of transplantation from HLA identical family members for the treatment of chronic myelogenous leukemia (CML) was examined in 45 patients transplanted in chronic phase (CP) (n = 39) or accelerated phase (AP) (n = 6). All patients received the same regimen of BU, 16 mg/kg orally and cyclophosphamide (CY), 120 mg/kg intravenously. Plasma concentrations of BU at steady state (CSSBU) during the dosing interval were measured for each patient. The mean CSSBU was 917 ng/mL (range, 642 to 1,749; median, 917; standard deviation, 213). Of patients with CSSBU below the median, seven (five of 18 in CP and two of four in AP) developed persistent cytogenetic relapse and three of these patients died. There were no relapses in patients with CSSBU above the median. The difference in the cumulative incidence of relapse between the two groups was statistically significant (P = .0003). CSSBU was the only statistically significant determinant of relapse in univariable or multivariable analysis. The 3-year survival estimates were 0.82 and 0.64 for patients with CSSBU above and below the median (P = .33). There was no statistically significant association of CSSBU with survival or nonrelapse mortality, although the power to detect a difference in survival between 0.82 and 0.64 was only 0.24, similarly CSSBU above the median was not associated with an increased risk of severe regimen-related toxicity. We conclude that low BU plasma levels are associated with an increased risk of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
Self-citationStorb, R., Deeg, H. J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Farewell, V., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Self-citationRegimen-related toxicity in patients undergoing bone marrow transplantation.
Bearman, S. I., Appelbaum, F. R., Buckner, C. D., Petersen, F. B., Fisher, L. D., Clift, R. A., & Thomas, E. D. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.10.1562 · Cited by 868
Self-citationSlavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Self-citationGanciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant
Goodrich, J. M., Bowden, R. A., Fisher, L., Keller, C., Schoch, G., & Meyers†, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00003 · Cited by 650
Self-citationBoeckh, M., Gooley, T., Myerson, D., Cunningham, T., Schoch, G., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 646
Self-citationBowden, R., Slichter, S., Sayers, M., Weisdorf, D., Cays, M., Schoch, G., Banaji, M., Haake, R., Welk, K., & Fisher, L. (1995) · Blood · doi:10.1182/blood.v86.9.3598.bloodjournal8693598 · Cited by 630
Self-citationA retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
Martin, P., Schoch, G., Fisher, L., Byers, V, Appelbaum, F., McDonald, G., Storb, R., & Hansen, J. (1991) · Blood · doi:10.1182/blood.v77.8.1821.1821 · Cited by 566
Self-citationMarrow Transplantation for the Treatment of Chronic Myelogenous Leukemia
THOMAS, E. D., CLIFT, R. A., FEFER, A., APPELBAUM, F. R., BEATTY, P., BENSINGER, W. I., BUCKNER, C. D., CHEEVER, M. A., DEEG, H. J., DONEY, K., et al. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-2-155 · Cited by 537
Self-citationA retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
Martin, P., Schoch, G. H., Fisher, L. D., Byers, V. S., Anasetti, C., Appelbaum, F. R., Pg, B., Doney, K., McDonald, G., & Sanders, J. (1990) · Blood · doi:10.1182/blood.v76.8.1464.1464 · Cited by 454
Self-citationBone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
Goldman, J. M., Apperley, J. F., Jones, L., Marcus, R., Goolden, A. W. G., Batchelor, R., Hale, G., Waldmann, H., Reid, C. D., Hows, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601233140403 · Cited by 397
Nash, R., Pepe, M., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F., Bowden, R., Deeg, H., & Doney, K. (1992) · Blood · doi:10.1182/blood.v80.7.1838.1838 · Cited by 377
Self-citationBREASTFEEDING IN DEVELOPING COUNTRIES
Villar, J., & Belizan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92755-0 · Cited by 375
Clift, R., Buckner, C., Thomas, E., Bensinger, W., Bowden, R., Bryant, E., Deeg, H., Doney, K., Fisher, L., & Hansen, J. (1994) · Blood · doi:10.1182/blood.v84.6.2036.2036 · Cited by 358
Self-citationSlattery, J. T., Sanders, J. E., Buckner, C. D., Schaffer, R. L., Lambert, K. W., Langer, F. P., Anasetti, C., Bensinger, W., Fisher, L. D., & Appelbaum, F. R. (1995) · PubMed · Cited by 343
Self-citationScharf, S., Smith, A., Hansen, J., McFarland, C., & Erlich, H. (1995) · Blood · doi:10.1182/blood.v85.7.1954.bloodjournal8571954 · Cited by 183
Self-citationGoldman, J. M., Szydlo, R., Horowitz, M., Rp, G., Ash, R., Atkinson, K., Ka, D., Gluckman, É., Herzig, R. H., & Marmont, A. (1993) · Blood · doi:10.1182/blood.v82.7.2235.2235 · Cited by 181
Treatment of chronic myeloid leukemia by marrow transplantation [editorial; comment] [see comments]
Ra, C., Appelbaum, F., & Thomas, E. D. (1993) · Blood · doi:10.1182/blood.v82.7.1954.bloodjournal8271954 · Cited by 112
Self-citationTen HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain
Petersdorf, E. W., Smith, A., Mickelson, E., Martin, P., & Hansen, J. (1991) · Immunogenetics · doi:10.1007/bf00230505 · Cited by 106
Self-citationMickelson, E., Smith, A. G., McKinney, S. K., Anderson, G., & Hansen, J. A. (1993) · Tissue Antigens · doi:10.1111/j.1399-0039.1993.tb01984.x · Cited by 59
Self-citation
Cited by
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Gyurkocza, B., & Sandmaier, B. M. (2014) · Blood · doi:10.1182/blood-2014-02-514778 · Cited by 614
McDonald, G. B., Slattery, J. T., Bouvier, M. E., Ren, S., Batchelder, A. L., Kalhorn, T. F., Schoch, H. G., Anasetti, C., & Gooley, T. (2003) · Blood · doi:10.1182/blood-2002-06-1860 · Cited by 383
Self-citationBartelink, I. H., Lalmohamed, A., van Reij, E. M. L., Dvorak, C. C., Savic, R. M., Zwaveling, J., Bredius, R. G. M., Egberts, A. C. G., Bierings, M., Kletzel, M., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30114-4 · Cited by 294
Russell, J. A., Tran, H. T., Quinlan, D., Chaudhry, A., Duggan, P., Brown, C., Stewart, D., Ruether, J. D., Morris, D., Glück, S., et al. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12374451 · Cited by 286
Metadata
- Authors
- Slattery, J. T., Clift, R. A., Buckner, C. D., Radich, J., Storer, B., Bensinger, W. I., Soll, E., Anasetti, C., Bowden, R., Bryant, E., Chauncey, T., Deeg, H. J., Doney, K. C., Flowers, M., Gooley, T., Hansen, J. A., Martin, P. J., McDonald, G. B., Nash, R., Petersdorf, E. W., Sanders, J. E., Schoch, G., Stewart, P., Storb, R., Sullivan, K. M., Thomas, E. D., Witherspoon, R. P., & Appelbaum, F. R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-04-15
- Volume
- 89
- Issue
- 8
- Pages
- 3055-3060
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2276362528
- Cited by
- 351
- References
- 23
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.